News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 2 Feb 2026 Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
News 30 Jan 2026 Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases
News 27 Jan 2026 DNDi and APHRC sign MoU to forge strategic alliance to bridge research and capacity enhancement gaps
News 4 Dec 2025 Dr Javid Abdelmoneim, Datuk Dr Mahathar bin Abd Wahab, Dr Taruna Madan, Violet Naanyu, and Dr Mario Santos Moreira join the Board of Directors at DNDi
News 26 Nov 2025 DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment
News 17 Nov 2025 New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations
News 3 Oct 2025 DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
News 8 Aug 2025 Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem
News 5 Aug 2025 ADB and DNDi sign MoU to advance healthcare cooperation on neglected diseases in Asia and the Pacific
